Careers  |  Sign In  |  Register  |   Twitter

High Hopes for New Hodgkin Lymphoma Treatment

According to CBS News, nivolumab, a PD-1 blocking drug may help patients with Hodgkin lymphoma who saw little or no effect with other therapies. A study published in the New England Journal of Medicine looked at 23 patients with the disease who were unresponsive to alternative treatments. After receiving nivolumab, four of the patients had no detectable tumor left, while 16 patients’ tumors shrunk by 50 percent or more.

Read the article published by CBS News.

Read the study published in the New England Journal of Medicine.